These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 6922790

  • 41. [Anti-atelectasis factor (surfactant) and hyaline membrane disease in premature infants].
    Saule H.
    Med Klin; 1975 Mar 07; 70(10):409-15. PubMed ID: 1091827
    [No Abstract] [Full Text] [Related]

  • 42. Effects of artificial ventilation on surfactant phospholipid metabolism in rabbits.
    Ennema JJ, Reijngoud DJ, Wildevuur CR, Egberts J.
    Respir Physiol; 1984 Oct 07; 58(1):15-28. PubMed ID: 6549078
    [Abstract] [Full Text] [Related]

  • 43. The effects of surfactant on haemodynamics in hyaline membrane disease.
    Skinner J.
    Arch Dis Child Fetal Neonatal Ed; 1997 Mar 07; 76(2):F67-9. PubMed ID: 9135282
    [No Abstract] [Full Text] [Related]

  • 44. Experimental neonatal group B streptococcal pneumonia: effect of a modified porcine surfactant on bacterial proliferation in ventilated near-term rabbits.
    Herting E, Jarstrand C, Rasool O, Curstedt T, Sun B, Robertson B.
    Pediatr Res; 1994 Dec 07; 36(6):784-91. PubMed ID: 7898987
    [Abstract] [Full Text] [Related]

  • 45. Distribution of surfactant, lung compliance, and aeration of preterm rabbit lungs after surfactant therapy and conventional and high-frequency oscillatory ventilation.
    Heldt GP, Merritt TA, Golembeski D, Gilliard N, Bloor C, Spragg R.
    Pediatr Res; 1992 Mar 07; 31(3):270-5. PubMed ID: 1561014
    [Abstract] [Full Text] [Related]

  • 46. Ductal shunting and effective systemic blood flow following single dose surfactant treatment in the premature baboon with hyaline membrane disease.
    Kinsella JP, Gerstmann DR, Gong AK, Taylor AF, deLemos RA.
    Biol Neonate; 1991 Mar 07; 60(5):283-91. PubMed ID: 1790252
    [Abstract] [Full Text] [Related]

  • 47. Surface active material: influence of lung distension and mechanical ventilation on secretion.
    Truog WE.
    Semin Perinatol; 1984 Oct 07; 8(4):300-7. PubMed ID: 6387926
    [No Abstract] [Full Text] [Related]

  • 48. Physiological basis and clinical implications of continuous negative chestwall pressure in hyaline membrane disease.
    Vidyasagar D.
    Int Anesthesiol Clin; 1974 Oct 07; 12(4):153-71. PubMed ID: 4613660
    [No Abstract] [Full Text] [Related]

  • 49. Surfactant replacement in neonatal and adult respiratory distress syndrome.
    Robertson B.
    Eur J Anaesthesiol; 1984 Dec 07; 1(4):335-43. PubMed ID: 6549536
    [Abstract] [Full Text] [Related]

  • 50. Pulmonary surfactant replacement in respiratory distress syndrome.
    Vidyasagar D, Shimada S.
    Clin Perinatol; 1987 Dec 07; 14(4):991-1015. PubMed ID: 3322633
    [Abstract] [Full Text] [Related]

  • 51. Mechanical ventilation effect on surfactant content, function, and lung compliance in the newborn rat.
    Martinez F, Lewis J, Copland I, Engelberts D, Kavanagh BP, Post M, Schurch S, Belik J.
    Pediatr Res; 2004 Jul 07; 56(1):19-25. PubMed ID: 15128929
    [Abstract] [Full Text] [Related]

  • 52. Hyaline membrane disease. Telling it like it was.
    Tooley WH.
    Am Rev Respir Dis; 1977 Jun 07; 115(6 Pt 2):19-28. PubMed ID: 326112
    [No Abstract] [Full Text] [Related]

  • 53. Effects of tracheal instillation of natural surfactant in premature lambs. I. Clinical and autopsy findings.
    Adams FH, Towers B, Osher AB, Ikegami M, Fujiwara T, Nozaki M.
    Pediatr Res; 1978 Aug 07; 12(8):841-8. PubMed ID: 581094
    [Abstract] [Full Text] [Related]

  • 54. Decreased surfactant dose-response after delayed administration to preterm rabbits.
    Seidner SR, Ikegami M, Yamada T, Rider ED, Castro R, Jobe AH.
    Am J Respir Crit Care Med; 1995 Jul 07; 152(1):113-20. PubMed ID: 7599809
    [Abstract] [Full Text] [Related]

  • 55. Natural surfactant for neonatal respiratory distress syndrome in very premature infants: a 1992 update.
    Gortner L.
    J Perinat Med; 1992 Jul 07; 20(6):409-19. PubMed ID: 1293266
    [Abstract] [Full Text] [Related]

  • 56. Artificial surfactant therapy for hyaline membrane disease.
    Wigglesworth JS.
    Arch Dis Child; 1980 Oct 07; 55(10):753-4. PubMed ID: 6893647
    [No Abstract] [Full Text] [Related]

  • 57. Comparison of the effects of high frequency oscillation and controlled mechanical ventilation on hyaline membrane formation in a rabbit model of the neonatal respiratory distress syndrome.
    Niblett DJ, Sandhar BK, Dunnill MS, Sykes MK.
    Br J Anaesth; 1989 Jun 07; 62(6):628-36. PubMed ID: 2502167
    [Abstract] [Full Text] [Related]

  • 58. Tracheal aspirate surface tension in babies with hyaline membrane disease: effects of synthetic surfactant replacement.
    McMillan DD, Singhal N, Shukla AK, Schürch S.
    Pediatr Pulmonol; 1998 Sep 07; 26(3):173-82. PubMed ID: 9773912
    [Abstract] [Full Text] [Related]

  • 59. Hyaline membrane disease treated with bovine surfactant.
    Smyth JA, Metcalfe IL, Duffty P, Possmayer F, Bryan MH, Enhorning G.
    Pediatrics; 1983 Jun 07; 71(6):913-7. PubMed ID: 6687937
    [Abstract] [Full Text] [Related]

  • 60. [Treatment of hyaline membrane disease by administration of exogenous surfactant].
    Bonte F, Dehan M, de Fontanges A, Lindenbaum A, Perret L, Puisieux F.
    Arch Fr Pediatr; 1985 May 07; 42(5):397-402. PubMed ID: 3907577
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.